The role of reactive oxygen species in β-adrenergic signaling in cardiomyocytes from mice with the metabolic syndrome

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Llano Diez, Monica ^a   Sinclair, Jon ^a   Yamada, Takashi ^a,c   Zong, Mei ^b   Fauconnier, Jeremy ^a,d   Zhang, Shi Jin ^a   Katz, Abram ^a,e   Jardemark, Kent ^a   Westerblad, Håkan ^a   Andersson, Daniel C ^a   Lanner, Johanna T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d INSERM   (France)

^e ARIEL UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; REACTIVE OXYGEN METABOLITE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; HYDROGEN PEROXIDE; ISOPRENALINE;

ADRENERGIC SYSTEM; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; BETA ADRENERGIC SIGNALING; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIAC MUSCLE CELL; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ASSAY; HEART MUSCLE CONTRACTILITY; IMMUNOFLUORESCENCE TEST; LIVER MITOCHONDRION; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CARDIOMYOPATHIES; DRUG EFFECTS; ELECTROSTIMULATION; HEART CONTRACTION; LIPID DIET; METABOLISM; MITOCHONDRION; OBESITY; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PRIMARY CELL CULTURE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM; CARDIOMYOPATHIES; DIET, HIGH-FAT; ELECTRIC STIMULATION; HYDROGEN PEROXIDE; ISOPROTERENOL; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OBESITY; ORGAN CULTURE TECHNIQUES; PRIMARY CELL CULTURE; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84999652745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167090     Document Type: Article

References (65)

1. Callow AD. Cardiovascular disease 2005-the global picture. Vascul Pharmacol. 2006; 45:302-7. Epub 2006/11/01. doi: 10.1016/j.vph.2006.08.010 PMID: 17074537
2. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol. 2005; 67:69-98. Epub 2005/02/16. doi: 10.1146/annurev.physiol.67.040403.114521 PMID: 15709953
3. Spooner PM. Sudden cardiac death: influence of diabetes. Diabetes Obes Metab. 2008; 10:523-32. Epub 2007/04/25. doi: 10.1111/j.1463-1326.2007.00723.x PMID: 17451424
4. Mellor KM, Ritchie RH, Delbridge LM. Reactive oxygen species and insulin-resistant cardiomyopathy. Clin Exp Pharmacol Physiol. 2010; 37:222-8. Epub 2009/08/13. doi: 10.1111/j.1440-1681.2009.05274. x PMID: 19671065
5. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2007; 49:241-8. Epub 2006/12/28. doi: 10.1161/01.HYP.0000254415.31362.a7 PMID: 17190878
6. 2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes. Circ Res. 2002; 91:601-9. PMID: 12364388
7. Tu VC, Bahl JJ, Chen QM. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Exp Ther. 2002; 300:1101-10. PMID: 11861821
8. Kowluru RA, Engerman RL, Kern TS. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res. 2000; 32:67-74. PMID: 10625218
9. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005; 115:500-8. doi: 10.1172/JCI200524408 PMID: 15765131
10. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009; 84:705-12. doi: 10.1016/j.lfs.2009.02.026 PMID: 19281826
11. Andersson DC, Fauconnier J, Yamada T, Lacampagne A, Zhang SJ, Katz A, et al. Mitochondrial production of reactive oxygen species contributes to the β-adrenergic stimulation of mouse cardiomyocytes. J Physiol. 2011; 589:1791-801. doi: 10.1113/jphysiol.2010.202838 PMID: 21486840
12. 2+ waves during beta-adrenergic receptor stimulation in rabbit cardiomyocytes. J Physiol. 2012; 590:3291-304. doi: 10.1113/jphysiol.2012.230748 PMID: 22586224
13. Bugger H, Abel ED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci. 2008; 114:195-210. doi: 10.1042/CS20070166 PMID: 18184113
14. Harmancey R, Wilson CR, Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension. 2008; 52:181-7. doi: 10.1161/HYPERTENSIONAHA.108.110031 PMID: 18574077
15. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347:305-13. doi: 10.1056/NEJMoa020245 PMID: 12151467
16. Tentolouris N, Liatis S, Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci. 2006; 1083:129-52. doi: 10.1196/annals.1367.010 PMID: 17148737
17. Nicolson GL. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem. 2007; 100:1352-69. doi: 10.1002/jcb.21247 PMID: 17243117
18. 2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes. 2005; 54:2375-81. PMID: 16046304
19. Dong F, Li Q, Sreejayan N, Nunn JM, Ren J. Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes. 2007; 56:2201-12. doi: 10.2337/db06-1596 PMID: 17575086
20. Mulligan C, Kondakala S, Yang EJ, Stokes JV, Stewart JA, Kaplan BL, et al. Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls Promotes hepatic steatosis in male ob/ob mice. Environ Toxicol. 2016.
21. Panchenko PE, Voisin S, Jouin M, Jouneau L, Prezelin A, Lecoutre S, et al. Expression of epigenetic machinery genes is sensitive to maternal obesity and weight loss in relation to fetal growth in mice. Clin Epigenetics. 2016; 8:22. doi: 10.1186/s13148-016-0188-3 PMID: 26925174
22. Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun. 2002; 294:798-805. doi: 10.1016/S0006-291X(02)00557-0 PMID: 12061777
23. Harper JM, Durkee SJ, Smith-Wheelock M, Miller RA. Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock. Exp Gerontol. 2005; 40:303-14. doi: 10.1016/j.exger.2005.01.002 PMID: 15820611
24. Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells. Proceedings of the National Academy of Sciences. 2010; 107:13426-31.
25. Nickel AG, von Hardenberg A, Hohl M, Loffler JR, Kohlhaas M, Becker J, et al. Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab. 2015; 22:472-84. doi: 10.1016/j.cmet.2015.07.008 PMID: 26256392
26. Toye AA, Lippiat JD, Proks P, Shimomura K, Bentley L, Hugill A, et al. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia. 2005; 48:675-86. doi: 10.1007/s00125-005-1680-z PMID: 15729571
27. 2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes. 2006; 55:2077-83. doi: 10.2337/db05-1613 PMID: 16804078
28. Fauconnier J, Lanner JT, Sultan A, Zhang SJ, Katz A, Bruton JD, et al. Insulin potentiates TRPC3-mediated cation currents in normal but not in insulin-resistant mouse cardiomyocytes. Cardiovasc Res. 2007; 73:376-85. doi: 10.1016/j.cardiores.2006.10.018 PMID: 17156765
29. 2+ handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes. 2007; 56:1136-42. doi: 10.2337/db06-0739 PMID: 17229941
30. 2+ signaling. Basic Res Cardiol. 2016; 111:34. doi: 10.1007/s00395-016-0551-8 PMID: 27071401
31. Bass A, Brdiczka D, Eyer P, Hofer S, Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem. 1969; 10(2):198-206. PMID: 4309865
32. Bruton JD, Place N, Yamada T, Silva JP, Andrade FH, Dahlstedt AJ, et al. Reactive oxygen species and fatigue-induced prolonged low-frequency force depression in skeletal muscle fibres of rats, mice and SOD2 overexpressing mice. J Physiol. 2008; 586:175-84. doi: 10.1113/jphysiol.2007.147470 PMID: 18006575
33. Wibom R, Hagenfeldt L, von Dobeln U. Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples. Anal Biochem. 2002; 311:139-51. PMID: 12470673
34. 2+ release complex and actin underlie arthritis-induced muscle weakness. Ann Rheum Dis. 2015; 74:1907-14. doi: 10.1136/annrheumdis-2013-205007 PMID: 24854355
35. 2+ channel currents in guinea-pig ventricular myocytes. J Physiol. 2002; 541:731-40. doi: 10.1113/jphysiol.2002.019729 PMID: 12068036
36. Chu G, Kranias EG. Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse models. Basic Res Cardiol. 2002; 97 Suppl 1:I43-I8.
37. Hagemann D, Xiao RP. Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc Med. 2002; 12:51-6. PMID: 11852250
38. Crocini C, Coppini R, Ferrantini C, Yan P, Loew LM, Tesi C, et al. Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure. PNAS. 2014; 111:15196-201. doi: 10.1073/pnas.1411557111 PMID: 25288764
39. 2-Adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010; 327:1653-7. doi: 10.1126/science.1185988 PMID: 20185685
40. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res. 2006; 71:310-21. doi: 10.1016/j.cardiores.2006.02.019 PMID: 16581043
41. Lanner JT, Georgiou DK, Joshi AD, Hamilton SL. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol. 2010; 2:a003996. doi: 10.1101/cshperspect.a003996 PMID: 20961976
42. Fu Y, Westenbroek RE, Scheuer T, Catterall WA. Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700. PNAS. 2014; 111:16598-603. doi: 10.1073/pnas.1419129111 PMID: 25368181
43. 2+ channel from the beta2 adrenergic receptor. EMBO J. 2016; 35:1330-45. doi: 10.15252/embj.201593409 PMID: 27103070
44. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. 2004; 53:2366-74. PMID: 15331547
45. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes. 2006; 55:466-73. PMID: 16443782
46. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005; 1734:112-26. doi: 10.1016/j.bbalip.2005.03.005 PMID: 15904868
47. 2+ in mitochondrial myopathy. Human Mol Genet. 2009; 18:278-88.
48. Powers SK, Ji LL, Kavazis AN, Jackson MJ. Reactive oxygen species: impact on skeletal muscle. Compr Physiol. 2011; 1:941-69. doi: 10.1002/cphy.c100054 PMID: 23737208
49. Zhang Y, Tocchetti CG, Krieg T, Moens AL. Oxidative and nitrosative stress in the maintenance of myocardial function. Free Radic Biol Med. 2012; 53:1531-40. doi: 10.1016/j.freeradbiomed.2012.07.010 PMID: 22819981
50. Zhang M, Perino A, Ghigo A, Hirsch E, Shah AM. NADPH Oxidases in Heart Failure: Poachers or Gamekeepers? Antioxid Redox Signal. 2013; 18:1024-41. doi: 10.1089/ars.2012.4550 PMID: 22747566
51. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. PNAS. 2010; 107:15565-70. doi: 10.1073/pnas. 1002178107 PMID: 20713697
52. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel J-L, Hasenfuss G, et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003; 41:2164-71. PMID: 12821241
53. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006; 127:397-408. doi: 10.1016/j.cell.2006.09.024 PMID: 17055439
54. Board PG, Menon D. Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta. 2013; 1830:3267-88. doi: 10.1016/j.bbagen.2012.11.019 PMID: 23201197
55. Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves AE, et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest. 2013; 123:4888-99. doi: 10.1172/JCI66218 PMID: 24135141
56. Cortassa S, O'Rourke B, Aon MA. Redox-optimized ROS balance and the relationship between mitochondrial respiration and ROS. Biochim Biophys Acta. 2014; 1837:287-95. doi: 10.1016/j.bbabio.2013. 11.007 PMID: 24269780
57. Nagasaka S, Katoh H, Niu CF, Matsui S, Urushida T, Satoh H, et al. Protein kinase A catalytic subunit alters cardiac mitochondrial redox state and membrane potential via the formation of reactive oxygen species. Circ J. 2007; 71:429-36. PMID: 17322647
58. Cheng AJ, Bruton JD, Lanner JT, Westerblad H. Antioxidant treatments do not improve force recovery after fatiguing stimulation of mouse skeletal muscle fibres. J Physiol. 2015; 593:457-72. doi: 10.1113/jphysiol.2014.279398 PMID: 25630265
59. Jeong EM, Chung J, Liu H, Go Y, Gladstein S, Farzaneh-Far A, et al. Role of mitochondrial oxidative stress in glucose tolerance, insulin resistance, and cardiac diastolic dysfunction. J Am Heart Assoc. 2016; 5.
60. Sverdlov AL, Elezaby A, Behring JB, Bachschmid MM, Luptak I, Tu VH, et al. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II. J Mol Cell Cardiol. 2015; 78:165-73. doi: 10.1016/j.yjmcc.2014.07.018 PMID: 25109264
61. Diniz YS, Santos PP, Assalin HB, Souza GA, Rocha KK, Ebaid GM, et al. Conjugated linoleic acid and cardiac health: oxidative stress and energetic metabolism in standard and sucrose-rich diets. Eur J Pharmacol. 2008; 579:318-25. doi: 10.1016/j.ejphar.2007.11.008 PMID: 18054909
62. Nandhini AT, Thirunavukkarasu V, Ravichandran MK, Anuradha CV. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med J. 2005; 46:82-7. PMID: 15678290
63. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Cardiac lipids and antioxidant status in high fructose rats and the effect of alpha-lipoic acid. Nutr Metab Cardiovasc Dis. 2004; 14:351-7. PMID: 15853119
64. Blake R, Trounce IA. Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta. 2014; 1840:1404-12. doi: 10.1016/j.bbagen.2013.11.007 PMID: 24246956
65. Fu Q, Xu B, Liu Y, Parikh D, Li J, Li Y, et al. Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts. Diabetes. 2014; 63:2676-89. doi: 10.2337/db13-1763 PMID: 24677713